Categories: Articles

EU Approves Smallpox Vaccine ‘Imanvex’ For Use Against Monkeypox

The European Commission has approved a smallpox vaccine Imanvex for use against monkeypox after the World Health Organization declared monkeypox a global health emergency, the Danish drugmaker that developed the jab said on Monday.

“The European Commission has extended the marketing authorization for the company’s smallpox vaccine, Imanvex, to include protection from monkeypox” in line with a recommendation by the EU’s medicines watchdog, Bavarian Nordic said in a statement. “The approval… is valid in all European Union Member States as well as in Iceland, Liechtenstein, and Norway.”

On Saturday, the WHO declared the monkeypox outbreak, which has affected nearly 16,000 people in 72 countries, to be a global health emergency — the highest alarm it can sound.

Imanvex has been approved in the EU since 2013 for the prevention of smallpox.

Imanvex was also considered a potential vaccine for monkeypox because of the similarity between the monkeypox virus and the smallpox virus. Monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.

The first symptoms of monkeypox are fever, headaches, muscle pain, and back pain during the days. Rashes subsequently appear on the face, the palms of hands, and so the less of the feet, followed by lesions, spots, and finally scabs. The government has told the citizens not to panic at all and follow the instructions being offered by the government for their safety.

The sudden surge in the cases led to the need for a vaccine

A surge in monkeypox infections has been reported since early May outside the West and Central African countries where the disease has long been endemic. The EMA carries out a scientific assessment of drugs any medicine should be marketed or not. However, under EU law the EMA has no authority to permit marketing in the different EU countries. It is the European Commission which is the authorizing body and takes a legally binding decision based on EMA’s recommendation.

Ria Soda

Recent Posts

Ascendion Accelerates AI Innovation: New AI Studio Launched in Hyderabad

Ascendion's Hyderabad AI Studio is designed to bring "Engineering to the Power of AI" tools…

3 hours ago

Monitra Health Announces Grant of U.S. Patent for Advanced Wireless Cardiac Monitoring Technology

Monitra Healthcare Private Limited, a pioneer in health monitoring technologies, proudly announces the grant of…

3 hours ago

Presenting India’s Most Epic KFC in the Sky

KFC just did something EPIC for its latest campaign 'Taste The Epic', with Action hero…

4 hours ago

The Rise of Premium Luxury Residences: How NCR is Setting New Standards

Over the years, Delhi-NCR has emerged as a hotspot for premium luxury residences with its…

4 hours ago

Progility Technologies Secures Contract to Enhance Cochin International Airport’s Digital Infrastructure

Progility Technologies, a leading provider of Unified Communications, Collaborations, Data and Cyber security solutions, is…

5 hours ago

Royalti Achieves an Unprecedented 200 Crores Sales at Oberoi Garden City Launch

Royalti, a distinguished real estate consulting firm in the high-end and luxury market has set…

5 hours ago